Showing 1 - 13 results of 13 for search 'M. A. Morozova', query time: 0.03s
Refine Results
-
1
Options of dyslipidemia treatment at non-alcoholic fatty liver disease by M. V. Mayevskaya, M. A. Morozova
Published 2018-08-01
Article -
2
Hepatopulmonary syndrome by V. T. Ivashkin, M. A. Morozova, M. V. Mayevskaya
Published 2018-08-01
Article -
3
Acute respiratory viral infections: possibilities of symptomatic therapy of patients by G. N. Nikiforova, V. M. Svistushkin, A. V. Zolotova, M. A. Morozova
Published 2021-04-01
Article -
4
-
5
-
6
-
7
Antioxidants in the Treatment of Chronic Diffuse Liver Diseases (the Results of the “MAXAR” Observational Program) by M. V. Mayevskaya, V. T. Ivashkin, V. D. Lunkov, S. P. Kryzhanovskiy, I. Yu. Pirogova, Ch. S. Pavlov, M. S. Zharkova, A. G. Beniashvili, M. A. Morozova
Published 2018-11-01
Article -
8
-
9
Efficacy and safety of netakimab in patients with psoriatic arthritis: results of the phase III PATERA clinical study by T. V. Korotaeva, V. I. Mazurov, A. M. Lila, I. Z. Gaydukova, A. L. Bakulev, A. V. Samtsov, V. R. Khairutdinov, A. V. Eremeeva, M. A. Morozova
Published 2020-11-01
Article -
10
Efficacy and safety of сepeginterferon alfa-2b in double treatment regimen (cepeginterferon alfa-2b and ribavirin) of antiviral therapy in patients with chronic hepatitis C genotyp... by A. I. Pavlov, S. M. Kirillov, D. S. Ponomarenko, A. K. Havanshanov, J. V. Fadina, I. V. Bobkova, V. I. Vasenko, G. A. Volodina, T. Yu. Kulikova, Yu. N. Linkova, M. A. Morozova
Published 2016-11-01
Article -
11
-
12
Levilimab clinical efficacy for interleukin-6 receptor inhibition in COVID-19 and its potential for treating cytokine release syndrome of other aetiologies by N. V. Lomakin, B. A. Bakirov, G. H. Musaev, V. V. Popov, E. A. Smolyarchuk, Yu. N. Linkova, D. V. Bogdan, A. V. Eremeeva, P. S. Pukhtinskaia, M. A. Morozova, A. V. Zinkina-Orikhan, A. A. Lutckii
Published 2022-12-01
Article -
13
The efficacy and safety of double (cepeginterferon alfa-2b and ribavirin) and triple (simeprevir, cepeginterferon alfa 2b and ribavirin) treatment regimens in chronic hepatitis C p... by N. P. Blokhina, E. A. Nurmuhametova, M. G. Rusanova, I. V. Gagarina, E. S. Mar’jamova, N. A. Kuznetsova, T. V. Mar’janovskaja, T. V. Lopatina, O. V. Kuzina, I. N. Alekseeva, E. N. Shurenkova, A. V. Devjatkin, Yu. N. Linkova, M. A. Morozova
Published 2016-07-01
Article